Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
44
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Guerrier Ron | Sr. VP and Chief Info. Officer | 2 | $0 | $0 | 2018-12-20 |
| Seiz Brian | Sr. VP, Specialty | 11 | $0 | $0 | 2018-12-20 |
| Phillips Bradley E | VP, Controller and CAO | 4 | $0 | $0 | 2018-12-20 |
| Anderson Phyllis S. | Sr. VP & Ch. Marketing Officer | 30 | $0 | $234.3K | 2018-12-20 |
| Akins Martin P. | Sr. VP & General Counsel | 29 | $0 | $0 | 2018-12-20 |
| Neville Everett | Sr. VP, Sup. Chain & Specialty | 34 | $0 | $1.05M | 2018-12-20 |
| Granger Elder | Director | 11 | $0 | $0 | 2018-12-20 |
| Sample Neal J. | Sr. VP & Ch. Information Off. | 14 | $0 | $0 | 2018-12-20 |
| Queller David A | Sr. VP, Sales and Account Mgmt | 29 | $0 | $0 | 2018-12-20 |
| HAVEL JAMES M | Executive VP and CFO | 9 | $0 | $0 | 2018-12-20 |
| Houston Christine | Sr. Vice President, Operations | 60 | $0 | $6.33M | 2018-12-20 |
| Miller Steven B | Sr. VP & Chief Med. Officer | 53 | $0 | $3.03M | 2018-12-20 |
| Stettin Glen D. | Sr. VP, Clin. Res. & New Sol. | 57 | $0 | $8.39M | 2018-12-20 |
| Wade Sara E | Sr. VP, Ch. Human Res. Off. | 48 | $0 | $2.45M | 2018-12-20 |
| DeLaney William J III | Director | 27 | $0 | $0 | 2018-12-20 |
| Mergenthaler Frank | Director | 41 | $0 | $0 | 2018-12-20 |
| Breen Maura C | Director | 52 | $0 | $2.58M | 2018-12-20 |
| MAZZARELLA KATHLEEN M | Director | 2 | $0 | $0 | 2018-12-20 |
| ARLOTTA JOHN | CEO, eviCore healthcare | 2 | $0 | $0 | 2018-12-20 |
| WENTWORTH TIMOTHY C | President & CEO | 58 | $489.0K | $7.45M | 2018-12-20 |
| MYERS WOODROW A JR | Director | 62 | $0 | $4.14M | 2018-12-20 |
| STERNBERG SEYMOUR | Director | 61 | $0 | $4.78M | 2018-12-20 |
| Paz George | President, Chairman & CEO | 112 | $0 | $64.61M | 2018-12-20 |
| LAHOWCHIC NICHOLAS | Director | 61 | $0 | $3.68M | 2018-12-20 |
| PALMORE RODERICK A | Director | 14 | $0 | $0 | 2018-12-20 |
| MAC MAHON THOMAS P | Director | 56 | $297.9K | $2.60M | 2018-12-20 |
| ROPER WILLIAM L | Director | 39 | $0 | $3.07M | 2018-12-20 |
| McGinnis Christopher A | VP, Controller & Ch. Acct. Off | 11 | $0 | $166.0K | 2017-03-08 |
| SLUSSER ERIC | Exec. VP & CFO | 8 | $0 | $0 | 2017-03-08 |
| Fotsch Donald | SVP, Pharm. Serv. & Mem. Exp. | 7 | $0 | $0 | 2016-09-09 |
| BENANAV GARY G | Director | 38 | $0 | $2.58M | 2016-05-04 |
| Norton David A | Senior VP, Supply Chain | 21 | $0 | $1.38M | 2016-02-29 |
| Wimberly Gary | Sr. VP & Ch. Information Off. | 29 | $0 | $7.60M | 2015-06-09 |
| Knibb Christopher K | VP & Chief Accounting Officer | 8 | $0 | $0 | 2015-03-04 |
| Ebling Keith J. | Exec. VP and General Counsel | 113 | $0 | $32.19M | 2015-03-04 |
| PARKER JOHN O | Director | 32 | $0 | $2.03M | 2014-12-05 |
| IGNACZAK EDWARD B | Exec. VP, Sales and Mktg | 58 | $0 | $23.59M | 2014-10-29 |
| McNamee Patrick | Exec. VP and COO | 66 | $0 | $21.58M | 2014-03-10 |
| Smith Catherine R | Exec. VP & CFO | 3 | $0 | $0 | 2014-03-05 |
| Harper Matthew D | VP & Interim CFO | 1 | $0 | $0 | 2013-11-18 |
| SKINNER SAMUEL K | Director | 35 | $0 | $44.0K | 2013-06-12 |
| Hall Jeffrey | EVP & Chief Financial Officer | 37 | $0 | $5.52M | 2013-05-15 |
| Elliott Kelley | Chief Accounting Officer | 30 | $0 | $1.04M | 2012-08-20 |
| POTTER MYRTLE S | Director | 17 | $0 | $839.4K | 2012-05-30 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Akins Martin P. | Sr. VP & General Counsel | D To issuer deriv | 2018-12-20 | 2018-12-21 | 5,946 | — | $0 | 0 | SEC↗ |
| Akins Martin P. | Sr. VP & General Counsel | D To issuer deriv | 2018-12-20 | 2018-12-21 | 4,280 | — | $0 | 0 | SEC↗ |
| Akins Martin P. | Sr. VP & General Counsel | D To issuer deriv | 2018-12-20 | 2018-12-21 | 1,547 | — | $0 | 0 | SEC↗ |
| Akins Martin P. | Sr. VP & General Counsel | D To issuer deriv | 2018-12-20 | 2018-12-21 | 1,964 | — | $0 | 0 | SEC↗ |
| Akins Martin P. | Sr. VP & General Counsel | D To issuer deriv | 2018-12-20 | 2018-12-21 | 34,909 | — | $0 | 0 | SEC↗ |
| Akins Martin P. | Sr. VP & General Counsel | D To issuer deriv | 2018-12-20 | 2018-12-21 | 48,735 | — | $0 | 0 | SEC↗ |
| Akins Martin P. | Sr. VP & General Counsel | D To issuer deriv | 2018-12-20 | 2018-12-21 | 47,254 | — | $0 | 0 | SEC↗ |
| Akins Martin P. | Sr. VP & General Counsel | D To issuer deriv | 2018-12-20 | 2018-12-21 | 461 | — | $0 | 0 | SEC↗ |
| Akins Martin P. | Sr. VP & General Counsel | D To issuer deriv | 2018-12-20 | 2018-12-21 | 5,626 | — | $0 | 0 | SEC↗ |
| Anderson Phyllis S. | Sr. VP & Ch. Marketing Offic | D To issuer deriv | 2018-12-20 | 2018-12-21 | 24,367 | — | $0 | 0 | SEC↗ |
| Anderson Phyllis S. | Sr. VP & Ch. Marketing Offic | D To issuer deriv | 2018-12-20 | 2018-12-21 | 4,264 | — | $0 | 0 | SEC↗ |
| Anderson Phyllis S. | Sr. VP & Ch. Marketing Offic | D To issuer deriv | 2018-12-20 | 2018-12-21 | 340 | — | $0 | 0 | SEC↗ |
| Anderson Phyllis S. | Sr. VP & Ch. Marketing Offic | D To issuer deriv | 2018-12-20 | 2018-12-21 | 23,627 | — | $0 | 0 | SEC↗ |
| Anderson Phyllis S. | Sr. VP & Ch. Marketing Offic | D To issuer deriv | 2018-12-20 | 2018-12-21 | 14,420 | — | $0 | 0 | SEC↗ |
| Anderson Phyllis S. | Sr. VP & Ch. Marketing Offic | D To issuer deriv | 2018-12-20 | 2018-12-21 | 6,722 | — | $0 | 0 | SEC↗ |
| Breen Maura C | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 6,402 | — | $0 | 0 | SEC↗ |
| Breen Maura C | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 7,032 | — | $0 | 0 | SEC↗ |
| Breen Maura C | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 5,604 | — | $0 | 0 | SEC↗ |
| Breen Maura C | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 8,006 | — | $0 | 0 | SEC↗ |
| Breen Maura C | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 5,872 | — | $0 | 0 | SEC↗ |
| Breen Maura C | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 6,870 | — | $0 | 0 | SEC↗ |
| DeLaney William J III | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 6,402 | — | $0 | 0 | SEC↗ |
| DeLaney William J III | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 7,032 | — | $0 | 0 | SEC↗ |
| DeLaney William J III | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 5,604 | — | $0 | 0 | SEC↗ |
| DeLaney William J III | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 8,006 | — | $0 | 0 | SEC↗ |
| DeLaney William J III | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 5,872 | — | $0 | 0 | SEC↗ |
| DeLaney William J III | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 4,580 | — | $0 | 0 | SEC↗ |
| Granger Elder | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 3,222 | — | $0 | 0 | SEC↗ |
| Granger Elder | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 8,006 | — | $0 | 0 | SEC↗ |
| Granger Elder | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 7,032 | — | $0 | 0 | SEC↗ |
| HAVEL JAMES M | Executive VP and CFO | D To issuer deriv | 2018-12-20 | 2018-12-21 | 24 | — | $0 | 0 | SEC↗ |
| Houston Christine | Executive Vice President | D To issuer deriv | 2018-12-20 | 2018-12-21 | 35,105 | — | $0 | 0 | SEC↗ |
| Houston Christine | Executive Vice President | D To issuer deriv | 2018-12-20 | 2018-12-21 | 64,975 | — | $0 | 0 | SEC↗ |
| Houston Christine | Executive Vice President | D To issuer deriv | 2018-12-20 | 2018-12-21 | 53,609 | — | $0 | 0 | SEC↗ |
| Houston Christine | Executive Vice President | D To issuer deriv | 2018-12-20 | 2018-12-21 | 1,229 | — | $0 | 0 | SEC↗ |
| Houston Christine | Executive Vice President | D To issuer deriv | 2018-12-20 | 2018-12-21 | 30,457 | — | $0 | 0 | SEC↗ |
| Houston Christine | Executive Vice President | D To issuer deriv | 2018-12-20 | 2018-12-21 | 25,288 | — | $0 | 0 | SEC↗ |
| LAHOWCHIC NICHOLAS | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 6,402 | — | $0 | 0 | SEC↗ |
| LAHOWCHIC NICHOLAS | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 5,872 | — | $0 | 0 | SEC↗ |
| LAHOWCHIC NICHOLAS | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 8,006 | — | $0 | 0 | SEC↗ |
| LAHOWCHIC NICHOLAS | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 5,604 | — | $0 | 0 | SEC↗ |
| LAHOWCHIC NICHOLAS | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 7,032 | — | $0 | 0 | SEC↗ |
| LAHOWCHIC NICHOLAS | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 4,580 | — | $0 | 0 | SEC↗ |
| MAC MAHON THOMAS P | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 5,872 | — | $0 | 0 | SEC↗ |
| MAC MAHON THOMAS P | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 7,032 | — | $0 | 0 | SEC↗ |
| MAC MAHON THOMAS P | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 8,006 | — | $0 | 0 | SEC↗ |
| MAC MAHON THOMAS P | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 6,402 | — | $0 | 0 | SEC↗ |
| MAC MAHON THOMAS P | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 5,604 | — | $0 | 0 | SEC↗ |
| MAC MAHON THOMAS P | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 6,870 | — | $0 | 0 | SEC↗ |
| Mergenthaler Frank | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 5,604 | — | $0 | 0 | SEC↗ |
| Mergenthaler Frank | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 6,402 | — | $0 | 0 | SEC↗ |
| Mergenthaler Frank | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 8,006 | — | $0 | 0 | SEC↗ |
| Mergenthaler Frank | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 6,870 | — | $0 | 0 | SEC↗ |
| Mergenthaler Frank | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 7,032 | — | $0 | 0 | SEC↗ |
| Mergenthaler Frank | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 5,872 | — | $0 | 0 | SEC↗ |
| Miller Steven B | Sr. VP & Chief Med. Officer | D To issuer deriv | 2018-12-20 | 2018-12-21 | 20,304 | — | $0 | 0 | SEC↗ |
| Miller Steven B | Sr. VP & Chief Med. Officer | D To issuer deriv | 2018-12-20 | 2018-12-21 | 17,507 | — | $0 | 0 | SEC↗ |
| Miller Steven B | Sr. VP & Chief Med. Officer | D To issuer deriv | 2018-12-20 | 2018-12-21 | 22,171 | — | $0 | 0 | SEC↗ |
| Miller Steven B | Sr. VP & Chief Med. Officer | D To issuer deriv | 2018-12-20 | 2018-12-21 | 5,818 | — | $0 | 0 | SEC↗ |
| Miller Steven B | Sr. VP & Chief Med. Officer | D To issuer deriv | 2018-12-20 | 2018-12-21 | 36,551 | — | $0 | 0 | SEC↗ |
| Miller Steven B | Sr. VP & Chief Med. Officer | D To issuer deriv | 2018-12-20 | 2018-12-21 | 41,347 | — | $0 | 0 | SEC↗ |
| Miller Steven B | Sr. VP & Chief Med. Officer | D To issuer deriv | 2018-12-20 | 2018-12-21 | 2,008 | — | $0 | 0 | SEC↗ |
| Miller Steven B | Sr. VP & Chief Med. Officer | D To issuer deriv | 2018-12-20 | 2018-12-21 | 2,325 | — | $0 | 0 | SEC↗ |
| Miller Steven B | Sr. VP & Chief Med. Officer | D To issuer deriv | 2018-12-20 | 2018-12-21 | 26,169 | — | $0 | 0 | SEC↗ |
| MYERS WOODROW A JR | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 5,604 | — | $0 | 0 | SEC↗ |
| MYERS WOODROW A JR | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 7,032 | — | $0 | 0 | SEC↗ |
| MYERS WOODROW A JR | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 8,006 | — | $0 | 0 | SEC↗ |
| MYERS WOODROW A JR | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 6,402 | — | $0 | 0 | SEC↗ |
| MYERS WOODROW A JR | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 1,872 | — | $0 | 0 | SEC↗ |
| Neville Everett | Exe VP, Strat, Sup Chn & Spc | D To issuer deriv | 2018-12-20 | 2018-12-21 | 16,272 | — | $0 | 0 | SEC↗ |
| Neville Everett | Exe VP, Strat, Sup Chn & Spc | D To issuer deriv | 2018-12-20 | 2018-12-21 | 51,980 | — | $0 | 0 | SEC↗ |
| Neville Everett | Exe VP, Strat, Sup Chn & Spc | D To issuer deriv | 2018-12-20 | 2018-12-21 | 42,643 | — | $0 | 0 | SEC↗ |
| Neville Everett | Exe VP, Strat, Sup Chn & Spc | D To issuer deriv | 2018-12-20 | 2018-12-21 | 952 | — | $0 | 0 | SEC↗ |
| Neville Everett | Exe VP, Strat, Sup Chn & Spc | D To issuer deriv | 2018-12-20 | 2018-12-21 | 9,121 | — | $0 | 0 | SEC↗ |
| Neville Everett | Exe VP, Strat, Sup Chn & Spc | D To issuer deriv | 2018-12-20 | 2018-12-21 | 9,387 | — | $0 | 0 | SEC↗ |
| Neville Everett | Exe VP, Strat, Sup Chn & Spc | D To issuer deriv | 2018-12-20 | 2018-12-21 | 2,237 | — | $0 | 0 | SEC↗ |
| PALMORE RODERICK A | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 3,654 | — | $0 | 0 | SEC↗ |
| PALMORE RODERICK A | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 7,032 | — | $0 | 0 | SEC↗ |
| PALMORE RODERICK A | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 8,006 | — | $0 | 0 | SEC↗ |
| PALMORE RODERICK A | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 3,382 | — | $0 | 0 | SEC↗ |
| Paz George | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 221,506 | — | $0 | 0 | SEC↗ |
| Paz George | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 249,770 | — | $0 | 0 | SEC↗ |
| Paz George | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 189,385 | — | $0 | 0 | SEC↗ |
| Paz George | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 8,006 | — | $0 | 0 | SEC↗ |
| Paz George | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 210,091 | — | $0 | 0 | SEC↗ |
| Paz George | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 209,358 | — | $0 | 0 | SEC↗ |
| Queller David A | Sr. VP, Sales and Account Mg | D To issuer deriv | 2018-12-20 | 2018-12-21 | 729 | — | $0 | 0 | SEC↗ |
| Queller David A | Sr. VP, Sales and Account Mg | D To issuer deriv | 2018-12-20 | 2018-12-21 | 51,980 | — | $0 | 0 | SEC↗ |
| Queller David A | Sr. VP, Sales and Account Mg | D To issuer deriv | 2018-12-20 | 2018-12-21 | 53,609 | — | $0 | 0 | SEC↗ |
| Queller David A | Sr. VP, Sales and Account Mg | D To issuer deriv | 2018-12-20 | 2018-12-21 | 32,334 | — | $0 | 0 | SEC↗ |
| Queller David A | Sr. VP, Sales and Account Mg | D To issuer deriv | 2018-12-20 | 2018-12-21 | 29,599 | — | $0 | 0 | SEC↗ |
| ROPER WILLIAM L | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 6,402 | — | $0 | 0 | SEC↗ |
| ROPER WILLIAM L | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 7,032 | — | $0 | 0 | SEC↗ |
| ROPER WILLIAM L | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 5,604 | — | $0 | 0 | SEC↗ |
| ROPER WILLIAM L | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 8,006 | — | $0 | 0 | SEC↗ |
| ROPER WILLIAM L | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 5,872 | — | $0 | 0 | SEC↗ |
| ROPER WILLIAM L | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 6,870 | — | $0 | 0 | SEC↗ |
| Sample Neal J. | Executive VP & COO | D To issuer deriv | 2018-12-20 | 2018-12-21 | 47,254 | — | $0 | 0 | SEC↗ |
| Sample Neal J. | Executive VP & COO | D To issuer deriv | 2018-12-20 | 2018-12-21 | 38,988 | — | $0 | 0 | SEC↗ |
| Sample Neal J. | Executive VP & COO | D To issuer deriv | 2018-12-20 | 2018-12-21 | 317 | — | $0 | 0 | SEC↗ |
| Seiz Brian | Sr. VP, Specialty | D To issuer deriv | 2018-12-20 | 2018-12-21 | 6,919 | — | $0 | 0 | SEC↗ |
| Seiz Brian | Sr. VP, Specialty | D To issuer deriv | 2018-12-20 | 2018-12-21 | 5,835 | — | $0 | 0 | SEC↗ |
| Seiz Brian | Sr. VP, Specialty | D To issuer deriv | 2018-12-20 | 2018-12-21 | 4,639 | — | $0 | 0 | SEC↗ |
| Seiz Brian | Sr. VP, Specialty | D To issuer deriv | 2018-12-20 | 2018-12-21 | 5,888 | — | $0 | 0 | SEC↗ |
| Seiz Brian | Sr. VP, Specialty | D To issuer deriv | 2018-12-20 | 2018-12-21 | 19,165 | — | $0 | 0 | SEC↗ |
| Seiz Brian | Sr. VP, Specialty | D To issuer deriv | 2018-12-20 | 2018-12-21 | 8,160 | — | $0 | 0 | SEC↗ |
| Seiz Brian | Sr. VP, Specialty | D To issuer deriv | 2018-12-20 | 2018-12-21 | 5,529 | — | $0 | 0 | SEC↗ |
| STERNBERG SEYMOUR | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 5,872 | — | $0 | 0 | SEC↗ |
| STERNBERG SEYMOUR | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 6,402 | — | $0 | 0 | SEC↗ |
| STERNBERG SEYMOUR | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 5,604 | — | $0 | 0 | SEC↗ |
| STERNBERG SEYMOUR | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 7,032 | — | $0 | 0 | SEC↗ |
| STERNBERG SEYMOUR | Director | D To issuer deriv | 2018-12-20 | 2018-12-21 | 8,006 | — | $0 | 0 | SEC↗ |
| Stettin Glen D. | Sr. VP, Clin. Res. & New Sol | D To issuer deriv | 2018-12-20 | 2018-12-21 | 23,996 | — | $0 | 0 | SEC↗ |
| Stettin Glen D. | Sr. VP, Clin. Res. & New Sol | D To issuer deriv | 2018-12-20 | 2018-12-21 | 24,019 | — | $0 | 0 | SEC↗ |
| Stettin Glen D. | Sr. VP, Clin. Res. & New Sol | D To issuer deriv | 2018-12-20 | 2018-12-21 | 31,678 | — | $0 | 0 | SEC↗ |
| Stettin Glen D. | Sr. VP, Clin. Res. & New Sol | D To issuer deriv | 2018-12-20 | 2018-12-21 | 30,715 | — | $0 | 0 | SEC↗ |
| Stettin Glen D. | Sr. VP, Clin. Res. & New Sol | D To issuer deriv | 2018-12-20 | 2018-12-21 | 1,501 | — | $0 | 0 | SEC↗ |
| Stettin Glen D. | Sr. VP, Clin. Res. & New Sol | D To issuer deriv | 2018-12-20 | 2018-12-21 | 27,234 | — | $0 | 0 | SEC↗ |
| Wade Sara E | Sr. VP and Ch. Human Res. Of | D To issuer deriv | 2018-12-20 | 2018-12-21 | 50,798 | — | $0 | 0 | SEC↗ |
| Wade Sara E | Sr. VP and Ch. Human Res. Of | D To issuer deriv | 2018-12-20 | 2018-12-21 | 52,390 | — | $0 | 0 | SEC↗ |
| Wade Sara E | Sr. VP and Ch. Human Res. Of | D To issuer deriv | 2018-12-20 | 2018-12-21 | 39,724 | — | $0 | 0 | SEC↗ |
| Wade Sara E | Sr. VP and Ch. Human Res. Of | D To issuer deriv | 2018-12-20 | 2018-12-21 | 1,368 | — | $0 | 0 | SEC↗ |
| Wade Sara E | Sr. VP and Ch. Human Res. Of | D To issuer deriv | 2018-12-20 | 2018-12-21 | 27,234 | — | $0 | 0 | SEC↗ |
| Wade Sara E | Sr. VP and Ch. Human Res. Of | D To issuer deriv | 2018-12-20 | 2018-12-21 | 4,596 | — | $0 | 0 | SEC↗ |
| Wade Sara E | Sr. VP and Ch. Human Res. Of | D To issuer deriv | 2018-12-20 | 2018-12-21 | 15,983 | — | $0 | 0 | SEC↗ |
| Wade Sara E | Sr. VP and Ch. Human Res. Of | D To issuer deriv | 2018-12-20 | 2018-12-21 | 38,071 | — | $0 | 0 | SEC↗ |
| WENTWORTH TIMOTHY C | President & CEO | D To issuer deriv | 2018-12-20 | 2018-12-21 | 140,115 | — | $0 | 0 | SEC↗ |
| WENTWORTH TIMOTHY C | President & CEO | D To issuer deriv | 2018-12-20 | 2018-12-21 | 2,388 | — | $0 | 0 | SEC↗ |
| WENTWORTH TIMOTHY C | President & CEO | D To issuer deriv | 2018-12-20 | 2018-12-21 | 271,714 | — | $0 | 0 | SEC↗ |
| WENTWORTH TIMOTHY C | President & CEO | D To issuer deriv | 2018-12-20 | 2018-12-21 | 123,064 | — | $0 | 0 | SEC↗ |
| WENTWORTH TIMOTHY C | President & CEO | D To issuer deriv | 2018-12-20 | 2018-12-21 | 33,069 | — | $0 | 0 | SEC↗ |
| WENTWORTH TIMOTHY C | President & CEO | D To issuer deriv | 2018-12-20 | 2018-12-21 | 106,240 | — | $0 | 0 | SEC↗ |
| WENTWORTH TIMOTHY C | President & CEO | D To issuer deriv | 2018-12-20 | 2018-12-21 | 43,081 | — | $0 | 0 | SEC↗ |
| WENTWORTH TIMOTHY C | President & CEO | D To issuer deriv | 2018-12-20 | 2018-12-21 | 94,140 | — | $0 | 0 | SEC↗ |
| Akins Martin P. | Sr. VP & General Counsel | D To issuer | 2018-12-20 | 2018-12-21 | 46,219 | — | $0 | 0 | SEC↗ |
| Anderson Phyllis S. | Sr. VP & Ch. Marketing Offic | D To issuer | 2018-12-20 | 2018-12-21 | 17,317 | — | $0 | 0 | SEC↗ |
| ARLOTTA JOHN | CEO, eviCore healthcare | D To issuer | 2018-12-20 | 2018-12-21 | 6,688 | — | $0 | 0 | SEC↗ |
| Breen Maura C | Director | D To issuer | 2018-12-20 | 2018-12-21 | 27,305 | — | $0 | 0 | SEC↗ |
| DeLaney William J III | Director | D To issuer | 2018-12-20 | 2018-12-21 | 14,989 | — | $0 | 0 | SEC↗ |
| Granger Elder | Director | D To issuer | 2018-12-20 | 2018-12-21 | 6,523 | — | $0 | 0 | SEC↗ |
| Guerrier Ron | Sr. VP and Chief Info. Offic | D To issuer | 2018-12-20 | 2018-12-21 | 10,199 | — | $0 | 0 | SEC↗ |
| HAVEL JAMES M | Executive VP and CFO | D To issuer | 2018-12-20 | 2018-12-21 | 57,833 | — | $0 | 0 | SEC↗ |
| Houston Christine | Executive Vice President | D To issuer | 2018-12-20 | 2018-12-21 | 98,010 | — | $0 | 0 | SEC↗ |
| LAHOWCHIC NICHOLAS | Director | D To issuer | 2018-12-20 | 2018-12-21 | 36,647 | — | $0 | 0 | SEC↗ |
| MAC MAHON THOMAS P | Director | D To issuer | 2018-12-20 | 2018-12-21 | 59,628 | — | $0 | 0 | SEC↗ |
| MAZZARELLA KATHLEEN M | Director | D To issuer | 2018-12-20 | 2018-12-21 | 2,466 | — | $0 | 0 | SEC↗ |
| Mergenthaler Frank | Director | D To issuer | 2018-12-20 | 2018-12-21 | 38,005 | — | $0 | 0 | SEC↗ |
| Miller Steven B | Sr. VP & Chief Med. Officer | D To issuer | 2018-12-20 | 2018-12-21 | 43,800 | — | $0 | 0 | SEC↗ |
| MYERS WOODROW A JR | Director | D To issuer | 2018-12-20 | 2018-12-21 | 14,318 | — | $0 | 0 | SEC↗ |
| Neville Everett | Exe VP, Strat, Sup Chn & Spc | D To issuer | 2018-12-20 | 2018-12-21 | 31,049 | — | $0 | 0 | SEC↗ |
| PALMORE RODERICK A | Director | D To issuer | 2018-12-20 | 2018-12-21 | 7,381 | — | $0 | 0 | SEC↗ |
| Paz George | Director | D To issuer | 2018-12-20 | 2018-12-21 | 132,527 | — | $0 | 0 | SEC↗ |
| Paz George | Director | D To issuer | 2018-12-20 | 2018-12-21 | 828,550 | — | $0 | 0 | SEC↗ |
| Paz George | Director | D To issuer | 2018-12-20 | 2018-12-21 | 132,850 | — | $0 | 0 | SEC↗ |
| Phillips Bradley E | VP, Controller and CAO | D To issuer | 2018-12-20 | 2018-12-21 | 14,881 | — | $0 | 0 | SEC↗ |
| Queller David A | Sr. VP, Sales and Account Mg | D To issuer | 2018-12-20 | 2018-12-21 | 52,799 | — | $0 | 0 | SEC↗ |
| ROPER WILLIAM L | Director | D To issuer | 2018-12-20 | 2018-12-21 | 18,918 | — | $0 | 0 | SEC↗ |
| ROPER WILLIAM L | Director | D To issuer | 2018-12-20 | 2018-12-21 | 52 | — | $0 | 0 | SEC↗ |
| Sample Neal J. | Executive VP & COO | D To issuer | 2018-12-20 | 2018-12-21 | 43,122 | — | $0 | 0 | SEC↗ |
| Seiz Brian | Sr. VP, Specialty | D To issuer | 2018-12-20 | 2018-12-21 | 32,118 | — | $0 | 0 | SEC↗ |
| STERNBERG SEYMOUR | Director | D To issuer | 2018-12-20 | 2018-12-21 | 4,375 | — | $0 | 0 | SEC↗ |
| STERNBERG SEYMOUR | Director | D To issuer | 2018-12-20 | 2018-12-21 | 453 | — | $0 | 0 | SEC↗ |
| STERNBERG SEYMOUR | Director | D To issuer | 2018-12-20 | 2018-12-21 | 2,758 | — | $0 | 0 | SEC↗ |
| Stettin Glen D. | Sr. VP, Clin. Res. & New Sol | D To issuer | 2018-12-20 | 2018-12-21 | 45,009 | — | $0 | 0 | SEC↗ |
| Wade Sara E | Sr. VP and Ch. Human Res. Of | D To issuer | 2018-12-20 | 2018-12-21 | 79,057 | — | $0 | 0 | SEC↗ |
| WENTWORTH TIMOTHY C | President & CEO | D To issuer | 2018-12-20 | 2018-12-21 | 157,261 | — | $0 | 0 | SEC↗ |
| WENTWORTH TIMOTHY C | President & CEO | D To issuer | 2018-12-20 | 2018-12-21 | 135,255 | — | $0 | 0 | SEC↗ |
| STERNBERG SEYMOUR | Director | G Gift | 2018-12-12 | 2018-12-21 | 9,892 | — | $0 | 4,375 | SEC↗ |
| Akins Martin P. | Sr. VP & General Counsel | F Tax w/h | 2018-11-30 | 2018-12-04 | 1,043 | $101.47 | $105.8K | 46,219 | SEC↗ |
| Miller Steven B | Sr. VP & Chief Med. Officer | F Tax w/h | 2018-11-30 | 2018-12-04 | 165 | $101.47 | $16.7K | 43,800 | SEC↗ |
| STERNBERG SEYMOUR | Director | G Gift | 2018-11-30 | 2018-12-21 | 9,893 | — | $0 | 14,267 | SEC↗ |
| Miller Steven B | Sr. VP & Chief Med. Officer | G Gift | 2018-11-28 | 2018-12-04 | 20,097 | — | $0 | 43,965 | SEC↗ |
| Paz George | Director | G Gift | 2018-11-28 | 2018-12-21 | 100,000 | — | $0 | 828,550 | SEC↗ |
| Seiz Brian | Sr. VP, Specialty | F Tax w/h | 2018-11-21 | 2018-11-26 | 381 | $95.33 | $36.3K | 32,118 | SEC↗ |
| LAHOWCHIC NICHOLAS | Director | G Gift | 2018-11-20 | 2018-12-21 | 5,197 | — | $0 | 36,647 | SEC↗ |
| MAC MAHON THOMAS P | Director | S Sale | 2018-11-07 | 2018-11-09 | 5,234 | $99.50 | $520.8K | 0 | SEC↗ |
| MAC MAHON THOMAS P | Director | G Gift | 2018-11-06 | 2018-11-09 | 5,234 | — | $0 | 59,628 | SEC↗ |
| MAC MAHON THOMAS P | Director | G Gift | 2018-11-06 | 2018-11-09 | 5,234 | — | $0 | 5,234 | SEC↗ |
| Akins Martin P. | Sr. VP & General Counsel | G Gift | 2018-11-05 | 2018-12-04 | 1,721 | — | $0 | 47,262 | SEC↗ |
| Anderson Phyllis S. | Sr. VP & Ch. Marketing Offic | F Tax w/h | 2018-10-30 | 2018-11-01 | 292 | $95.42 | $27.9K | 17,317 | SEC↗ |
| DeLaney William J III | Director | M Exercise deriv | 2018-10-26 | 2018-10-30 | 5,464 | — | $0 | 0 | SEC↗ |
| DeLaney William J III | Director | F Tax w/h | 2018-10-26 | 2018-10-30 | 2,707 | $94.28 | $255.2K | 14,989 | SEC↗ |
| DeLaney William J III | Director | M Exercise | 2018-10-26 | 2018-10-30 | 5,464 | $46.70 | $255.2K | 17,696 | SEC↗ |
| Houston Christine | Executive Vice President | M Exercise deriv | 2018-08-10 | 2018-08-14 | 12,898 | — | $0 | 0 | SEC↗ |
| Houston Christine | Executive Vice President | M Exercise | 2018-08-10 | 2018-08-14 | 12,898 | $53.05 | $684.2K | 110,908 | SEC↗ |
| Houston Christine | Executive Vice President | S Sale | 2018-08-10 | 2018-08-14 | 12,898 | $85.00 | $1.10M | 98,010 | SEC↗ |
| WENTWORTH TIMOTHY C | President & CEO | G Gift | 2018-07-10 | 2018-12-21 | 4,482 | — | $0 | 157,261 | SEC↗ |
| WENTWORTH TIMOTHY C | President & CEO | G Gift | 2018-07-10 | 2018-12-21 | 4,482 | — | $0 | 135,255 | SEC↗ |
| Houston Christine | Executive Vice President | M Exercise deriv | 2018-06-13 | 2018-06-15 | 10,000 | — | $0 | 12,898 | SEC↗ |
| Houston Christine | Executive Vice President | S Sale | 2018-06-13 | 2018-06-15 | 10,000 | $82.28 | $822.8K | 98,010 | SEC↗ |
| Houston Christine | Executive Vice President | M Exercise | 2018-06-13 | 2018-06-15 | 10,000 | $53.05 | $530.5K | 108,010 | SEC↗ |
| Breen Maura C | Director | A Award | 2018-05-10 | 2018-05-14 | 2,818 | — | $0 | 27,305 | SEC↗ |
| DeLaney William J III | Director | A Award | 2018-05-10 | 2018-05-14 | 2,818 | — | $0 | 12,232 | SEC↗ |
| Granger Elder | Director | A Award | 2018-05-10 | 2018-05-14 | 2,818 | — | $0 | 6,523 | SEC↗ |
| MAZZARELLA KATHLEEN M | Director | A Award | 2018-05-10 | 2018-05-14 | 2,466 | — | $0 | 2,466 | SEC↗ |
| LAHOWCHIC NICHOLAS | Director | A Award | 2018-05-10 | 2018-05-14 | 2,818 | — | $0 | 41,844 | SEC↗ |
| MAC MAHON THOMAS P | Director | A Award | 2018-05-10 | 2018-05-14 | 2,818 | — | $0 | 64,862 | SEC↗ |
| Mergenthaler Frank | Director | A Award | 2018-05-10 | 2018-05-14 | 2,818 | — | $0 | 38,005 | SEC↗ |
| MYERS WOODROW A JR | Director | A Award | 2018-05-10 | 2018-05-14 | 2,818 | — | $0 | 14,318 | SEC↗ |
| PALMORE RODERICK A | Director | A Award | 2018-05-10 | 2018-05-14 | 2,818 | — | $0 | 7,381 | SEC↗ |
| Paz George | Director | A Award | 2018-05-10 | 2018-05-14 | 2,818 | — | $0 | 890,554 | SEC↗ |
| ROPER WILLIAM L | Director | A Award | 2018-05-10 | 2018-05-14 | 2,818 | — | $0 | 18,918 | SEC↗ |
| STERNBERG SEYMOUR | Director | A Award | 2018-05-10 | 2018-05-14 | 2,818 | — | $0 | 24,613 | SEC↗ |
| Guerrier Ron | Sr. VP and Chief Info. Offic | A Award | 2018-05-09 | 2018-05-11 | 10,199 | — | $0 | 10,199 | SEC↗ |
| Neville Everett | Exe VP, Strat, Sup Chn & Spc | F Tax w/h | 2018-05-04 | 2018-05-08 | 522 | $70.22 | $36.7K | 31,049 | SEC↗ |
| WENTWORTH TIMOTHY C | President & CEO | F Tax w/h | 2018-05-04 | 2018-05-08 | 3,537 | $70.22 | $248.4K | 185,064 | SEC↗ |
| Breen Maura C | Director | M Exercise deriv | 2018-04-27 | 2018-05-01 | 7,466 | — | $0 | 0 | SEC↗ |
| Breen Maura C | Director | M Exercise | 2018-04-27 | 2018-05-01 | 7,466 | $57.59 | $430.0K | 30,108 | SEC↗ |
| Breen Maura C | Director | F Tax w/h | 2018-04-27 | 2018-05-01 | 5,621 | $76.49 | $430.0K | 24,487 | SEC↗ |
| LAHOWCHIC NICHOLAS | Director | M Exercise deriv | 2018-04-26 | 2018-04-30 | 7,466 | — | $0 | 0 | SEC↗ |
| MAC MAHON THOMAS P | Director | M Exercise deriv | 2018-04-26 | 2018-04-30 | 7,466 | — | $0 | 0 | SEC↗ |
| Mergenthaler Frank | Director | M Exercise deriv | 2018-04-26 | 2018-04-30 | 7,466 | — | $0 | 0 | SEC↗ |
| LAHOWCHIC NICHOLAS | Director | M Exercise | 2018-04-26 | 2018-04-30 | 7,466 | $57.59 | $430.0K | 39,026 | SEC↗ |
| MAC MAHON THOMAS P | Director | M Exercise | 2018-04-26 | 2018-04-30 | 7,466 | $57.59 | $430.0K | 62,044 | SEC↗ |
| Mergenthaler Frank | Director | M Exercise | 2018-04-26 | 2018-04-30 | 7,466 | $57.59 | $430.0K | 35,187 | SEC↗ |
| WENTWORTH TIMOTHY C | President & CEO | G Gift | 2018-04-06 | 2018-12-21 | 45,327 | — | $0 | 152,779 | SEC↗ |
| WENTWORTH TIMOTHY C | President & CEO | G Gift | 2018-04-06 | 2018-12-21 | 45,327 | — | $0 | 139,737 | SEC↗ |
| Houston Christine | Executive Vice President | M Exercise deriv | 2018-03-15 | 2018-03-19 | 19,889 | — | $0 | 0 | SEC↗ |
| Houston Christine | Executive Vice President | M Exercise | 2018-03-15 | 2018-03-19 | 19,889 | $43.77 | $870.5K | 117,899 | SEC↗ |
| Houston Christine | Executive Vice President | S Sale | 2018-03-15 | 2018-03-19 | 19,889 | $76.69 | $1.53M | 98,010 | SEC↗ |
| STERNBERG SEYMOUR | Director | G Gift | 2018-03-12 | 2018-12-21 | 453 | — | $0 | 453 | SEC↗ |
| STERNBERG SEYMOUR | Director | G Gift | 2018-03-12 | 2018-12-21 | 453 | — | $0 | 24,160 | SEC↗ |
| Phillips Bradley E | VP, Controller and CAO | A Award | 2018-03-07 | 2018-03-08 | 3,813 | — | $0 | 14,881 | SEC↗ |
| ARLOTTA JOHN | CEO, eviCore healthcare | A Award | 2018-03-06 | 2018-03-08 | 6,688 | — | $0 | 6,688 | SEC↗ |
| Seiz Brian | Sr. VP, Specialty | A Award | 2018-03-06 | 2018-03-08 | 8,026 | — | $0 | 32,499 | SEC↗ |
| Akins Martin P. | Sr. VP & General Counsel | A Award | 2018-03-06 | 2018-03-08 | 16,720 | — | $0 | 43,296 | SEC↗ |
| Akins Martin P. | Sr. VP & General Counsel | F Tax w/h | 2018-03-06 | 2018-03-08 | 2,950 | $74.58 | $220.0K | 48,983 | SEC↗ |
| Akins Martin P. | Sr. VP & General Counsel | A Award | 2018-03-06 | 2018-03-08 | 8,637 | — | $0 | 51,933 | SEC↗ |
| Anderson Phyllis S. | Sr. VP & Ch. Marketing Offic | F Tax w/h | 2018-03-06 | 2018-03-08 | 1,098 | $74.58 | $81.9K | 17,609 | SEC↗ |
| Anderson Phyllis S. | Sr. VP & Ch. Marketing Offic | A Award | 2018-03-06 | 2018-03-08 | 3,617 | — | $0 | 18,707 | SEC↗ |
| Anderson Phyllis S. | Sr. VP & Ch. Marketing Offic | A Award | 2018-03-06 | 2018-03-08 | 6,688 | — | $0 | 15,090 | SEC↗ |
| HAVEL JAMES M | Executive VP and CFO | A Award | 2018-03-06 | 2018-03-08 | 18,392 | — | $0 | 53,332 | SEC↗ |
| HAVEL JAMES M | Executive VP and CFO | A Award | 2018-03-06 | 2018-03-08 | 4,501 | — | $0 | 57,833 | SEC↗ |
| Houston Christine | Executive Vice President | A Award | 2018-03-06 | 2018-03-08 | 18,392 | — | $0 | 92,496 | SEC↗ |
| Houston Christine | Executive Vice President | F Tax w/h | 2018-03-06 | 2018-03-08 | 3,817 | $74.58 | $284.7K | 98,010 | SEC↗ |
| Houston Christine | Executive Vice President | A Award | 2018-03-06 | 2018-03-08 | 9,331 | — | $0 | 101,827 | SEC↗ |
| Miller Steven B | Sr. VP & Chief Med. Officer | F Tax w/h | 2018-03-06 | 2018-03-08 | 3,101 | $74.58 | $231.3K | 64,062 | SEC↗ |
| Miller Steven B | Sr. VP & Chief Med. Officer | A Award | 2018-03-06 | 2018-03-08 | 7,332 | — | $0 | 67,163 | SEC↗ |
| Miller Steven B | Sr. VP & Chief Med. Officer | A Award | 2018-03-06 | 2018-03-08 | 12,373 | — | $0 | 59,831 | SEC↗ |
| Neville Everett | Exe VP, Strat, Sup Chn & Spc | A Award | 2018-03-06 | 2018-03-08 | 4,316 | — | $0 | 32,881 | SEC↗ |
| Neville Everett | Exe VP, Strat, Sup Chn & Spc | F Tax w/h | 2018-03-06 | 2018-03-08 | 1,310 | $74.58 | $97.7K | 31,571 | SEC↗ |
| Neville Everett | Exe VP, Strat, Sup Chn & Spc | A Award | 2018-03-06 | 2018-03-08 | 17,389 | — | $0 | 28,565 | SEC↗ |
| Paz George | Director | A Award | 2018-03-06 | 2018-03-08 | 46,988 | — | $0 | 887,736 | SEC↗ |
| Queller David A | Sr. VP, Sales and Account Mg | A Award | 2018-03-06 | 2018-03-08 | 8,595 | — | $0 | 56,115 | SEC↗ |
| Queller David A | Sr. VP, Sales and Account Mg | A Award | 2018-03-06 | 2018-03-08 | 14,881 | — | $0 | 47,520 | SEC↗ |
| Queller David A | Sr. VP, Sales and Account Mg | F Tax w/h | 2018-03-06 | 2018-03-08 | 3,316 | $74.58 | $247.3K | 52,799 | SEC↗ |
| Stettin Glen D. | Sr. VP, Clin. Res. & New Sol | A Award | 2018-03-06 | 2018-03-08 | 6,385 | — | $0 | 47,003 | SEC↗ |
| Stettin Glen D. | Sr. VP, Clin. Res. & New Sol | F Tax w/h | 2018-03-06 | 2018-03-08 | 1,994 | $74.58 | $148.7K | 45,009 | SEC↗ |
| Stettin Glen D. | Sr. VP, Clin. Res. & New Sol | A Award | 2018-03-06 | 2018-03-08 | 8,694 | — | $0 | 40,618 | SEC↗ |
| Wade Sara E | Sr. VP and Ch. Human Res. Of | A Award | 2018-03-06 | 2018-03-08 | 14,714 | — | $0 | 73,286 | SEC↗ |
| Wade Sara E | Sr. VP and Ch. Human Res. Of | F Tax w/h | 2018-03-06 | 2018-03-08 | 4,789 | $74.58 | $357.2K | 79,057 | SEC↗ |
| Wade Sara E | Sr. VP and Ch. Human Res. Of | A Award | 2018-03-06 | 2018-03-08 | 10,560 | — | $0 | 83,846 | SEC↗ |
| WENTWORTH TIMOTHY C | President & CEO | F Tax w/h | 2018-03-06 | 2018-03-08 | 12,808 | $74.58 | $955.2K | 188,601 | SEC↗ |
| WENTWORTH TIMOTHY C | President & CEO | A Award | 2018-03-06 | 2018-03-08 | 28,242 | — | $0 | 201,409 | SEC↗ |
| WENTWORTH TIMOTHY C | President & CEO | A Award | 2018-03-06 | 2018-03-08 | 80,257 | — | $0 | 173,167 | SEC↗ |
| Sample Neal J. | Executive VP & COO | A Award | 2018-03-06 | 2018-03-08 | 17,389 | — | $0 | 43,122 | SEC↗ |
| Miller Steven B | Sr. VP & Chief Med. Officer | M Exercise deriv | 2018-03-02 | 2018-03-06 | 20,348 | — | $0 | 0 | SEC↗ |
| Paz George | Director | M Exercise deriv | 2018-03-02 | 2018-03-06 | 161,666 | — | $0 | 0 | SEC↗ |
| Wade Sara E | Sr. VP and Ch. Human Res. Of | M Exercise deriv | 2018-03-02 | 2018-03-06 | 20,348 | — | $0 | 0 | SEC↗ |
| Miller Steven B | Sr. VP & Chief Med. Officer | M Exercise | 2018-03-02 | 2018-03-06 | 20,348 | $56.50 | $1.15M | 64,343 | SEC↗ |
| Miller Steven B | Sr. VP & Chief Med. Officer | F Tax w/h | 2018-03-02 | 2018-03-06 | 16,885 | $74.77 | $1.26M | 47,458 | SEC↗ |
| Paz George | Director | M Exercise | 2018-03-02 | 2018-03-06 | 161,666 | $56.50 | $9.13M | 980,826 | SEC↗ |
| Paz George | Director | F Tax w/h | 2018-03-02 | 2018-03-06 | 140,078 | $74.77 | $10.47M | 840,748 | SEC↗ |
| Wade Sara E | Sr. VP and Ch. Human Res. Of | F Tax w/h | 2018-03-02 | 2018-03-06 | 17,253 | $74.77 | $1.29M | 58,572 | SEC↗ |
| Wade Sara E | Sr. VP and Ch. Human Res. Of | M Exercise | 2018-03-02 | 2018-03-06 | 20,348 | $56.50 | $1.15M | 75,825 | SEC↗ |
| Neville Everett | Exe VP, Strat, Sup Chn & Spc | S Sale | 2018-03-01 | 2018-03-02 | 4,895 | $75.26 | $368.4K | 11,176 | SEC↗ |
| Paz George | Director | F Tax w/h | 2018-02-28 | 2018-03-02 | 10,831 | $75.45 | $817.2K | 819,160 | SEC↗ |
| Wade Sara E | Sr. VP and Ch. Human Res. Of | F Tax w/h | 2018-02-28 | 2018-03-02 | 2,970 | $75.45 | $224.1K | 55,477 | SEC↗ |
| WENTWORTH TIMOTHY C | President & CEO | F Tax w/h | 2018-02-28 | 2018-03-02 | 13,718 | $75.45 | $1.04M | 92,910 | SEC↗ |
| Stettin Glen D. | Sr. VP, Clin. Res. & New Sol | F Tax w/h | 2018-02-28 | 2018-03-02 | 1,791 | $75.45 | $135.1K | 31,924 | SEC↗ |
| Queller David A | Sr. VP, Sales and Account Mg | F Tax w/h | 2018-02-28 | 2018-03-02 | 3,265 | $75.45 | $246.3K | 32,639 | SEC↗ |
| Neville Everett | Exe VP, Strat, Sup Chn & Spc | F Tax w/h | 2018-02-28 | 2018-03-02 | 2,161 | $75.45 | $163.0K | 16,071 | SEC↗ |
| Miller Steven B | Sr. VP & Chief Med. Officer | F Tax w/h | 2018-02-28 | 2018-03-02 | 1,917 | $75.45 | $144.6K | 43,995 | SEC↗ |
| Houston Christine | Executive Vice President | F Tax w/h | 2018-02-28 | 2018-03-02 | 3,192 | $75.45 | $240.8K | 74,104 | SEC↗ |
| Anderson Phyllis S. | Sr. VP & Ch. Marketing Offic | F Tax w/h | 2018-02-28 | 2018-03-02 | 1,163 | $75.45 | $87.7K | 8,402 | SEC↗ |
| Akins Martin P. | Sr. VP & General Counsel | F Tax w/h | 2018-02-28 | 2018-03-02 | 965 | $75.45 | $72.8K | 26,576 | SEC↗ |
| Seiz Brian | Sr. VP, Specialty | F Tax w/h | 2018-02-28 | 2018-03-02 | 1,517 | $75.45 | $114.5K | 24,473 | SEC↗ |
| Sample Neal J. | Executive VP & COO | F Tax w/h | 2018-02-28 | 2018-03-02 | 2,881 | $75.45 | $217.4K | 25,733 | SEC↗ |
| Wade Sara E | Sr. VP and Ch. Human Res. Of | M Exercise deriv | 2018-02-22 | 2018-02-26 | 3,646 | — | $0 | 0 | SEC↗ |
| Wade Sara E | Sr. VP and Ch. Human Res. Of | F Tax w/h | 2018-02-22 | 2018-02-26 | 2,959 | $74.72 | $221.1K | 58,447 | SEC↗ |
| Wade Sara E | Sr. VP and Ch. Human Res. Of | M Exercise | 2018-02-22 | 2018-02-26 | 3,646 | $54.59 | $199.0K | 61,406 | SEC↗ |
| Akins Martin P. | Sr. VP & General Counsel | A Award deriv | 2018-02-01 | 2018-02-05 | 219 | $78.10 | $17.1K | 461 | SEC↗ |
| Anderson Phyllis S. | Sr. VP & Ch. Marketing Offic | A Award deriv | 2018-02-01 | 2018-02-05 | 155 | $78.10 | $12.1K | 340 | SEC↗ |
| HAVEL JAMES M | Executive VP and CFO | A Award deriv | 2018-02-01 | 2018-02-05 | 24 | $78.10 | $1.9K | 24 | SEC↗ |
| Houston Christine | Executive Vice President | A Award deriv | 2018-02-01 | 2018-02-05 | 244 | $78.10 | $19.1K | 1,229 | SEC↗ |
| Miller Steven B | Sr. VP & Chief Med. Officer | A Award deriv | 2018-02-01 | 2018-02-05 | 189 | $78.10 | $14.8K | 2,008 | SEC↗ |
| Neville Everett | Exe VP, Strat, Sup Chn & Spc | A Award deriv | 2018-02-01 | 2018-02-05 | 185 | $78.10 | $14.5K | 890 | SEC↗ |
| Queller David A | Sr. VP, Sales and Account Mg | A Award deriv | 2018-02-01 | 2018-02-05 | 214 | $78.10 | $16.7K | 729 | SEC↗ |
| Sample Neal J. | Executive VP & COO | A Award deriv | 2018-02-01 | 2018-02-05 | 207 | $78.10 | $16.1K | 317 | SEC↗ |
| Stettin Glen D. | Sr. VP, Clin. Res. & New Sol | A Award deriv | 2018-02-01 | 2018-02-05 | 172 | $78.10 | $13.4K | 1,501 | SEC↗ |
| Wade Sara E | Sr. VP and Ch. Human Res. Of | A Award deriv | 2018-02-01 | 2018-02-05 | 212 | $78.10 | $16.6K | 1,368 | SEC↗ |
| WENTWORTH TIMOTHY C | President & CEO | A Award deriv | 2018-02-01 | 2018-02-05 | 696 | $78.10 | $54.4K | 2,388 | SEC↗ |
| Paz George | Director | G Gift | 2018-01-22 | 2018-03-02 | 62,500 | — | $0 | 132,850 | SEC↗ |
| Paz George | Director | G Gift | 2018-01-22 | 2018-03-02 | 62,500 | — | $0 | 829,991 | SEC↗ |
| Paz George | Director | G Gift | 2018-01-22 | 2018-03-02 | 62,500 | — | $0 | 892,491 | SEC↗ |
| Paz George | Director | G Gift | 2018-01-22 | 2018-03-02 | 62,500 | — | $0 | 132,527 | SEC↗ |
| Stettin Glen D. | Sr. VP, Clin. Res. & New Sol | S Sale | 2018-01-11 | 2018-01-12 | 3,449 | $81.00 | $279.4K | 33,715 | SEC↗ |
| Stettin Glen D. | Sr. VP, Clin. Res. & New Sol | I Discretionary deriv | 2018-01-02 | 2018-01-04 | 635 | $75.23 | $47.8K | 1,488 | SEC↗ |
| Stettin Glen D. | Sr. VP, Clin. Res. & New Sol | M Exercise deriv | 2018-01-02 | 2018-01-04 | 159 | $75.23 | $11.9K | 1,329 | SEC↗ |
| Stettin Glen D. | Sr. VP, Clin. Res. & New Sol | S Sale | 2018-01-02 | 2018-01-04 | 3,448 | $76.00 | $262.0K | 37,055 | SEC↗ |